BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7657520)

  • 1. Correlation of differences in modulation of ras expression with metastatic competence of mouse mammary tumor subpopulations.
    Shekhar PV; Miller FR
    Invasion Metastasis; 1994-1995; 14(1-6):27-37. PubMed ID: 7657520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of first exon/intron sequences in the regulation of myc family oncogenic potency.
    Xu L; Wallen R; Patel V; DePinho RA
    Oncogene; 1993 Sep; 8(9):2547-53. PubMed ID: 8361763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
    Morrison BW; Leder P
    Oncogene; 1994 Dec; 9(12):3417-26. PubMed ID: 7970700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic potential of SP1 mouse mammary adenocarcinoma cells is differentially induced by activated and normal forms of c-H-ras.
    Waghorne C; Kerbel RS; Breitman ML
    Oncogene; 1987 May; 1(2):149-55. PubMed ID: 3325879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic factors and suppression of metastatic ability of v-Ha-ras-transfected rat mammary cancer cells.
    Ichikawa T; Ichikawa Y; Isaacs JT
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1607-10. PubMed ID: 1542651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection for spontaneous metastasis after calcium phosphate-mediated transfer of DNA.
    Muschel RJ
    Cancer Res; 1990 Sep; 50(17):5581-6. PubMed ID: 2201438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of Ha-ras-induced metastatic potential of SP1 mouse mammary tumors despite loss of the Ha-ras shuttle vector.
    Schlatter B; Waghorne CG
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):9986-90. PubMed ID: 1438249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of the first intron of c-H-ras in gene expression: anti-cancer elements in oncogenes.
    Hashimoto-Gotoh T; Kikuno R; Takahashi M; Honkawa H
    Anticancer Res; 1988; 8(5A):851-9. PubMed ID: 3052257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in p53 mutations in mouse mammary tumor subpopulations with different metastatic potential from the orthotopic site.
    Shekhar PV; Werdell J; Christman JK; Miller FR
    Anticancer Res; 1995; 15(3):815-20. PubMed ID: 7645964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma.
    Bera TK; Tsukamoto T; Panda DK; Huang T; Guzman RC; Hwang SI; Nandi S
    Biochem Biophys Res Commun; 1998 Jul; 248(3):835-40. PubMed ID: 9704014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory elements in the first intron of the mouse Ha-ras gene.
    Telliez JB; Plumb M; Balmain A; Bailleul B
    Mol Carcinog; 1995 Mar; 12(3):137-45. PubMed ID: 7893367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
    Kyprianou N; Isaacs JT
    Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harvey-ras mediated neoplastic development in the mouse mammary gland.
    Strange R; Aguilar-Cordova E; Young LJ; Billy HT; Dandekar S; Cardiff RD
    Oncogene; 1989 Mar; 4(3):309-15. PubMed ID: 2784851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors.
    Hundley JE; Koester SK; Troyer DA; Hilsenbeck SG; Barrington RE; Windle JJ
    Cancer Res; 1997 Feb; 57(4):600-3. PubMed ID: 9044833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
    Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
    Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of c-Ki-ras activation in N-methyl-N-nitrosourea-induced mammary carcinomas in pituitary-isografted mice.
    Guzman RC; Osborn RC; Swanson SM; Sakthivel R; Hwang SI; Miyamoto S; Nandi S
    Cancer Res; 1992 Oct; 52(20):5732-7. PubMed ID: 1394197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.
    Medina D; Kittrell FS; Oborn CJ; Schwartz M
    Cancer Res; 1993 Feb; 53(3):668-74. PubMed ID: 8425201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.
    Vorce RL; Goodman JI
    Mol Toxicol; 1989; 2(2):99-116. PubMed ID: 2702305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.